EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mandibular device treatment in obstructive sleep apnea -A structured therapy adjustment considering night-to-night variability night-to-night variability in mandibular devices

Greta Sophie Papenfuß, Inke R König, Christina Hagen, Alex Frydrychowicz, Fenja Zell, Alina Janna Ibbeken, Thorsten M Buzug, Ulrike Kirstein, Lina Kreft, Daniel Grünberg, Samer Hakim, Armin Steffen iD

Sleep and Breathing · 2024

DOI: 10.1007/s11325-024-03134-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sleep and Breathing, 2024. Verfasst von Greta Sophie Papenfuß und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, University of Lübeck, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Mandibular Advancement. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universität zu Lübeck.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mandibular advancement devices (MAD) are a well-established treatment option for obstructive sleep apnea (OSA). MAD are considered preferably for patients with mild to moderate OSA presenting with a elevated night-to-night variability (NNV). This study aimed to determine the treatment effect of MAD on NNV considering different protrusion distances and patient related outcome (PRO).

Methods

We conducted a prospective cohort analysis of patients before MAD with 60% and 80% of the maximum protrusion. OSA severity was assessed using a home-sleep test for two consecutive nights. PRO contained the Epworth Sleepiness Scale (ESS) and sleep related quality of life (FOSQ).

Results

Twenty patients with a median overweight body-mass-index of 27.1 (interquartile range (IQR) 16.3 kg/m²), with a mainly mild to moderate OSA with an apnea -hypopnea index (AHI) of 18.3 / h (IQR 17.7) and elevated ESS of 12.5 (IQR 8.0) were included. As opposed to 80%, 60% protrusion significantly but not 80% relevantly reduced AHI (60%%: 11.2 (IQR 5.5)/h, p = 0.01; 80%: 12.9 (IQR18,0)/h, p = 0.32) and improved the ESS (60%: 8.0 (IQR 10,0); 80%: 10 (IQR 9.0)), with therapy settings. No correlation could be detected between NNV and ESS, and FOSQ changes. Higher baseline NNV was associated with severe OSA ( p = 0.02) but not with gender, overweight, or status post-tonsillectomy.

Conclusions

OSA improvement is associated with lower NNV; both OSA and NNV are connected to the degree of protrusion. Therefore, higher NNV does not justify the exclusion of candidates for MAD treatment. PRO changes are not visibly affected by NNV but by general OSA changes. These findings may help to define and optimize future study designs for the primary outcome decision between objective OSA parameters and PRO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Apnea, ObstructiveMandibular AdvancementHumansMaleFemaleMiddle AgedAdultProspective StudiesPolysomnographyCohort StudiesQuality of Life

Stichwörter der Autor:innen

Mandibular advancement deviceNight-to-night variabilityObstructive sleep apneaPatient related outcome

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, University of Lübeck, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.
  • Institute of Medical Biometry and Statistics, University of Lübeck, Lübeck, Germany.
  • Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering IMTE, Lübeck, Germany.
  • Department of Radiology, University of Schleswig-Holstein, Campus Lübeck, Germany.
  • Institute of Medical Engineering, University of Lübeck, Lübeck, Germany.
  • HICAT GmbH, SICAT GmbH & Co. KG, Bonn, Germany.

ORCID-Profile: Armin Steffen

Förderung

  • Universität zu Lübeck

Zitieren

APA

Papenfuß, G. S., König, I. R., Hagen, C., Frydrychowicz, A., Zell, F., Ibbeken, A. J., Buzug, T. M., Kirstein, U., Kreft, L., Grünberg, D., Hakim, S., & Steffen, A. (2024). Mandibular device treatment in obstructive sleep apnea -A structured therapy adjustment considering night-to-night variability night-to-night variability in mandibular devices. Sleep and Breathing. https://doi.org/10.1007/s11325-024-03134-w

Vancouver

Papenfuß GS, König IR, Hagen C, Frydrychowicz A, Zell F, Ibbeken AJ, et al. Mandibular device treatment in obstructive sleep apnea -A structured therapy adjustment considering night-to-night variability night-to-night variability in mandibular devices. Sleep and Breathing. 2024. doi:10.1007/s11325-024-03134-w

BibTeX
@article{Papenfu2024,
  author = {Papenfuß, Greta Sophie and König, Inke R and Hagen, Christina and Frydrychowicz, Alex and Zell, Fenja and Ibbeken, Alina Janna and Buzug, Thorsten M and Kirstein, Ulrike and Kreft, Lina and Grünberg, Daniel and Hakim, Samer and Steffen, Armin},
  title = {Mandibular device treatment in obstructive sleep apnea -A structured therapy adjustment considering night-to-night variability night-to-night variability in mandibular devices},
  journal = {Sleep and Breathing},
  year = {2024},
  doi = {10.1007/s11325-024-03134-w}
}
Kostenlos starten →